Home/Filings/4/0000899243-17-023581
4//SEC Filing

Glasheen James Walter 4

Accession 0000899243-17-023581

CIK 0001484565other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 6:04 PM ET

Size

6.3 KB

Accession

0000899243-17-023581

Insider Transaction Report

Form 4
Period: 2017-10-02
Glasheen James Walter
Director10% Owner
Transactions
  • Award

    Common Stock

    2017-10-02$0.52/sh+13,154$6,84026,945 total
Holdings
  • Common Stock

    (indirect: See footnote)
    7,050,691
Footnotes (3)
  • [F1]Effective January 1, 2017, annual board and committee retainers payable to directors will be made in equivalent shares of the Issuer's common stock, on a quarterly basis.
  • [F2]The number of shares issuable in lieu of cash retainers was determined using the closing price per share of Issuer common stock on September 29, 2017, or $0.52.
  • [F3]Consists of shares held by Technology Partners Fund VII, L.P and Tehnology Partners Affiliates VII, L.P. or Technology Affiliates. James Glasheen is one of the managing members of Technology Partners and Technology Affiliates and has shared voting power over the shares of common stock beneficially owned by Technology Partners and Technology Affiliates. M r. Glasheen disclaims beneficial ownership of such securities, except to the extent, if any, of his pecuniary interest therein.

Issuer

SOLENO THERAPEUTICS INC

CIK 0001484565

Entity typeother

Related Parties

1
  • filerCIK 0001532830

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:04 PM ET
Size
6.3 KB